Drug Trial Radar · NCT04502862
A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma
Last checked: Nov 20, 2026Latest source record: Dec 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
202
Actual
Start
Aug 10, 2020
Primary completion
Oct 3, 2023
Study completion Nov 10, 2023
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- Collaborators
- Regeneron Pharmaceuticals
- First posted
- Aug 6, 2020
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: To assess the effect of dupilumab on sleep Secondary Objectives: * To evaluate the effect of dupilumab on additional participant reported sleep outcomes * To evaluate the effect of dupilumab on objective sleep assessment * To evaluate the effect of dupilumab on asthma symptoms * To evaluate the effect of dupilumab on lung function * To evaluate the safety of dupilumab
Conditions
- Asthma
Interventions
SAR231893Drug
Pharmaceutical form: Solution for injection; Route of administration: Subcutaneous
PlaceboDrug
Pharmaceutical form: Solution for injection; Route of administration: Subcutaneous
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Week 12 in Sleep Disturbance Score Using the Asthma Sleep Disturbance Questionnaire (ASDQ)Time frame: Baseline (Day -6 to Day 1) up to Week 12
Locations
55 sites in 11 countries. Site status is shown where the registry gives one.
Kern Allergy and Medical Research. Inc. Site Number : 8400003
Bakersfield, California
Todd Astor MD Site Number : 8400016
Culver City, California
Southern California Institute for Respiratory Diseases Site Number : 8400009
Los Angeles, California
Allergy & Asthma Associates of Santa Clara Valley Site Number : 8400001
San Jose, California
Asthma and Allergy Associates, PC Site Number : 8400011
Colorado Springs, Colorado
Sarasota Clinical Research Site Number : 8400012
Sarasota, Florida
Allergy & Asthma Specialists, PSC Site Number : 8400004
Owensboro, Kentucky
The Asthma and Allergy Center Site Number : 8400010
Bellevue, Nebraska
OK Clinical Research LLC Site Number : 8400005
Edmond, Oklahoma
Velocity Clinical Research, Medford Site Number : 8400007
Medford, Oregon
National Allergy and Asthma Research, LLC Site Number : 8400008
Charleston, South Carolina
TTS Research Site Number : 8400006
Boerne, Texas
Investigational Site Number : 0320002
Buenos Aires, Argentina
Investigational Site Number : 0320003
CABA, Buenos Aires, Argentina
Investigational Site Number : 0320001
CABA, Buenos Aires, Argentina
Investigational Site Number : 0320004
Rosario, Santa Fe Province, Argentina
Investigational Site Number : 0320005
Rosario, Santa Fe Province, Argentina
Investigational Site Number : 1240009
Québec, Canada
Investigational Site Number : 1240008
Windsor, Canada
Investigational Site Number : 1240012
Ajax, Ontario, Canada
Investigational Site Number : 1240005
Toronto, Ontario, Canada
Investigational Site Number : 2760002
Berlin, Germany
Investigational Site Number : 2760005
Frankfurt am Main, Germany
Investigational Site Number : 2760003
Hanover, Germany
Investigational Site Number : 2760001
Koblenz, Germany
Investigational Site Number : 2760004
Leipzig, Germany
Investigational Site Number : 2760006
Lübeck, Germany
Investigational Site Number : 3800005
Reggio Emilia, Italy
Investigational Site Number : 3800006
Monserrato, Cagliari, Italy
Investigational Site Number : 3800001
Orbassano, Torino, Italy
Investigational Site Number : 5280005
Arnhem, Netherlands
Investigational Site Number : 5280001
Breda, Netherlands
Investigational Site Number : 5280002
Leeuwarden, Netherlands
Investigational Site Number : 6200001
Aveiro, Portugal
Investigational Site Number : 6200007
Guimarães, Portugal
Investigational Site Number : 6200006
Lisbon, Portugal
Investigational Site Number : 6200003
Matosinhos Municipality, Portugal
Investigational Site Number : 6200004
Porto, Portugal
Investigational Site Number : 6430001
Moscow, Russia
Investigational Site Number : 6430002
Moscow, Russia
Showing 40 of 55 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.